Genincode

Legal firm Addleshaw Goddard’s corporate team in Scotland has advised on the initial public offering (IPO) and admission to the AIM market of the London Stock Exchange for innovative global healthcare firm, GENinCode. Specialising in cardiovascular disease risk assessment, GENinCode's products